Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-07-19
2011-07-19
Lukton, David (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S374000, C514S369000, C424S456000, C424S502000, C424S465000
Reexamination Certificate
active
07981911
ABSTRACT:
Improved pharmaceutical compositions are provided comprising one or more solubilized HIV protease inhibiting compounds having improved solubility properties in a medium and/or long chain fatty acid, or mixtures thereof, a pharmaceutically acceptable alcohol, and water.
REFERENCES:
patent: 5086165 (1992-02-01), Marshall et al.
patent: 5164300 (1992-11-01), Marshall et al.
patent: 5171662 (1992-12-01), Sharma
patent: 5183826 (1993-02-01), Bills et al.
patent: 5250563 (1993-10-01), Chen et al.
patent: 5256677 (1993-10-01), Sham et al.
patent: 5264223 (1993-11-01), Yamamoto et al.
patent: 5296604 (1994-03-01), Hanko et al.
patent: 5342625 (1994-08-01), Hauer et al.
patent: 5342922 (1994-08-01), Marshall et al.
patent: 5354866 (1994-10-01), Kempf et al.
patent: 5484801 (1996-01-01), Al-Razzak et al.
patent: 5541206 (1996-07-01), Kempf et al.
patent: 5756123 (1998-05-01), Yamamoto et al.
patent: 5914332 (1999-06-01), Sham et al.
patent: 5948436 (1999-09-01), Al-Razzak et al.
patent: 6232333 (2001-05-01), Lipari et al.
patent: 7141593 (2006-11-01), Alani et al.
patent: 7432294 (2008-10-01), Alani et al.
patent: 2505430 (1997-11-01), None
patent: 0 486 948 (2000-10-01), None
patent: 92/00750 (1992-01-01), None
patent: 94/14436 (1994-07-01), None
patent: 95/07696 (1995-03-01), None
patent: 95/09614 (1995-04-01), None
patent: 95/25504 (1995-09-01), None
patent: 97/01349 (1997-01-01), None
patent: 97/21685 (1997-06-01), None
patent: 98/22106 (1998-05-01), None
patent: 00/74677 (2000-12-01), None
Teva Opposition dated Feb. 1, 2010.
Reply to Teva Opposition dated Sep. 7, 2010.
Laboratorios Recalcine SA dated Oct. 28, 2010.
Alani Laman
Ghosh Soumojeet
Abbott Laboratories
Lukton David
Zhang Xu
LandOfFree
Pharmaceutical formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical formulations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2646543